Literature DB >> 23489061

Molecular characterization of 39 de novo sSMC: contribution to prognosis and genetic counselling, a prospective study.

N Marle1, D Martinet, A Aboura, G Joly-Helas, J Andrieux, E Flori, J Puechberty, F Vialard, D Sanlaville, S Fert Ferrer, G Bourrouillou, A C Tabet, B Quilichini, B Simon-Bouy, A Bazin, M Becker, H Stora, S Amblard, M Doco-Fenzy, D Molina Gomes, F Girard-Lemaire, M P Cordier, V Satre, A Schneider, N Lemeur, P Chambon, S Jacquemont, F Fellmann, A Vigouroux-Castera, R Molignier, A Delaye, E Pipiras, A Liquier, T Rousseau, A L Mosca, V Kremer, M Payet, C Rangon, F Mugneret, S Aho, L Faivre, P Callier.   

Abstract

Small supernumerary marker chromosomes (sSMCs) are structurally abnormal chromosomes that cannot be characterized by karyotype. In many prenatal cases of de novo sSMC, the outcome of pregnancy is difficult to predict because the euchromatin content is unclear. This study aimed to determine the presence or absence of euchromatin material of 39 de novo prenatally ascertained sSMC by array-comparative genomic hybridization (array-CGH) or single nucleotide polymorphism (SNP) array. Cases were prospectively ascertained from the study of 65,000 prenatal samples [0.060%; 95% confidence interval (CI), 0.042-0.082]. Array-CGH showed that 22 markers were derived from non-acrocentric markers (56.4%) and 7 from acrocentic markers (18%). The 10 additional cases remained unidentified (25.6%), but 7 of 10 could be further identified using fluorescence in situ hybridization; 69% of de novo sSMC contained euchromatin material, 95.4% of which for non-acrocentric markers. Some sSMC containing euchromatin had a normal phenotype (31% for non-acrocentric and 75% for acrocentric markers). Statistical differences between normal and abnormal phenotypes were shown for the size of the euchromatin material (more or less than 1 Mb, p = 0.0006) and number of genes (more or less than 10, p = 0.0009). This study is the largest to date and shows the utility of array-CGH or SNP array in the detection and characterization of de novo sSMC in a prenatal context.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  array-CGH; de novo sSMC; genotype-phenotype correlation; prenatal diagnosis; small supernumerary chromosome marker

Mesh:

Substances:

Year:  2013        PMID: 23489061     DOI: 10.1111/cge.12138

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  Decreased XY recombination and disturbed meiotic prophase I progression in an infertile 48, XYY, +sSMC man.

Authors:  Liu Wang; Zhipeng Xu; Furhan Iqbal; Liangwen Zhong; Yuanwei Zhang; Caiyun Wu; Guixiang Zhou; Hanwei Jiang; Ihtisham Bukhari; Howard J Cooke; Qinghua Shi
Journal:  Chromosome Res       Date:  2015-01-28       Impact factor: 5.239

2.  6q16.3q23.3 duplication associated with Prader-Willi-like syndrome.

Authors:  Laurent Desch; Nathalie Marle; Anne-Laure Mosca-Boidron; Laurence Faivre; Marie Eliade; Muriel Payet; Clemence Ragon; Julien Thevenon; Bernard Aral; Sylviane Ragot; Azarnouche Ardalan; Nabila Dhouibi; Candace Bensignor; Christel Thauvin-Robinet; Salima El Chehadeh; Patrick Callier
Journal:  Mol Cytogenet       Date:  2015-06-25       Impact factor: 2.009

3.  Design and validation of a pericentromeric BAC clone set aimed at improving diagnosis and phenotype prediction of supernumerary marker chromosomes.

Authors:  Chiara Castronovo; Emanuele Valtorta; Milena Crippa; Sara Tedoldi; Lorenza Romitti; Maria Cristina Amione; Silvana Guerneri; Daniela Rusconi; Lucia Ballarati; Donatella Milani; Enrico Grosso; Pietro Cavalli; Daniela Giardino; Maria Teresa Bonati; Lidia Larizza; Palma Finelli
Journal:  Mol Cytogenet       Date:  2013-10-30       Impact factor: 2.009

4.  Mosaic partial pericentromeric trisomy 8 and maternal uniparental disomy in a male patient with autism spectrum disorder.

Authors:  Dina F Ahram; Danae Stambouli; Aleksandra Syrogianni; Yasser Al-Sarraj; Spyridon Gerou; Hatem El-Shanti; Marios Kambouris
Journal:  Clin Case Rep       Date:  2016-10-21

5.  Clinical and molecular findings in nine new cases of tetrasomy 18p syndrome: FISH and array CGH characterization.

Authors:  Wafa Slimani; Hela Ben Khelifa; Sarra Dimassi; Fatma-Zohra Chioukh; Afef Jelloul; Molka Kammoun; Hanene Hannachi; Sarra Bouslah; Nesrine Jammali; Damien Sanlaville; Ali Saad; Soumaya Mougou-Zerelli
Journal:  Mol Cytogenet       Date:  2019-02-08       Impact factor: 2.009

6.  Molecular cytogenetic identification of small supernumerary marker chromosomes using chromosome microarray analysis.

Authors:  Huili Xue; Liangpu Xu; Hailong Huang; Yan Wang; Gang An; Min Zhang; Yuan Lin
Journal:  Mol Cytogenet       Date:  2019-03-11       Impact factor: 2.009

7.  Prenatal diagnosis and molecular cytogenetic identification of small supernumerary marker chromosomes: analysis of three prenatal cases using chromosome microarray analysis.

Authors:  Huili Xue; Xuemei Chen; Min Lin; Na Lin; Hailong Huang; Aili Yu; Liangpu Xu
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

8.  Two Separate Cases: Complex Chromosomal Abnormality Involving Three Chromosomes and Small Supernumerary Marker Chromosome in Patients with Impaired Reproductive Function.

Authors:  Tatyana V Karamysheva; Tatyana A Gayner; Vladimir V Muzyka; Konstantin E Orishchenko; Nikolay B Rubtsov
Journal:  Genes (Basel)       Date:  2020-12-17       Impact factor: 4.096

9.  Prenatal diagnosis of de novo small supernumerary marker chromosome 4q (4q11-q12): A case report.

Authors:  Reza Mohammadi; Raheleh Taheri; Fatemeh Shahriyari; Farnaz Feiz; Zahra Mohammadi; Sadegh Shirian; Reza Raoofian; Abdorrasoul Malekpour; Reza Pazhoomand
Journal:  Int J Reprod Biomed       Date:  2021-06-23

10.  C-banding and AgNOR-staining were still effective complementary methods to indentify chromosomal heteromorphisms and some structural abnormalities in prenatal diagnosis.

Authors:  Jian Jiang Zhu; Hong Qi; Li Rong Cai; Xiao Hui Wen; Wen Zeng; Guo Dong Tang; Yao Luo; Ran Meng; Xue Qun Mao; Shao Qin Zhang
Journal:  Mol Cytogenet       Date:  2019-09-18       Impact factor: 2.009

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.